Related Experiment Video
Updated: Jun 12, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
[Chinese expert consensus on the diagnosis and treatment of chronic graft-versus-host disease (2024)]
Insights
This updated consensus guides clinical practice for chronic graft-versus-host disease (cGVHD), a severe complication after stem cell transplants. It incorporates new therapies and research for better diagnosis and management.
Area of Science:
- Hematology
- Immunology
- Oncology
Context:
- Chronic graft-versus-host disease (cGVHD) is a significant complication of allogeneic hematopoietic stem cell transplantation (HSCT).
- cGVHD severely impacts patient survival and quality of life post-HSCT.
- Existing clinical guidelines require updates to reflect recent advancements.
Purpose:
- To revise and update the Chinese consensus on the diagnosis and management of cGVHD.
- To provide current, evidence-based guidance for clinicians treating cGVHD.
- To integrate novel therapeutic strategies and recent research findings into clinical practice.
Summary:
- The consensus incorporates the latest developments in cGVHD research and evidence-based medicine.
- Novel therapies, including targeted drugs, and advancements in clinical research have driven progress.
- This revised guideline aims to optimize the diagnosis, prevention, and treatment of cGVHD.
Impact:
- Improved clinical management strategies for cGVHD patients.
- Enhanced patient outcomes and quality of life following HSCT.
- Standardized and up-to-date guidance for healthcare professionals managing cGVHD.
Abstract:
Chronic graft-versus-host disease (cGVHD) is a common and severe complication following allogeneic hematopoietic stem cell transplantation, which significantly impacts patients' survival and quality of life. In recent years, notable progress has been made in the diagnosis, prevention, and treatment of cGVHD, driven by the emergence of novel therapies such as targeted drugs and the advancement of clinical research. This consensus, based on the latest developments in cGVHD research and growing data from evidence-based medicine, has been revised and updated from the "Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)" to better guide clinical practice.
More Related Videos
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
09:50Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
Published on: February 11, 2019
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...